SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trialFang Zheng, Guozhong Gong, Jing Ma et al.|International Journal of Infectious Diseases|2020Cited by 64
A Novel Protein Drug, Novaferon, as the Potential Antiviral Drug for COVID-19Fang Zheng, Guozhong Gong, Yanwen Zhou et al.|medRxiv|2020Cited by 14
Reply to “Novaferon, treatment in COVID-19 patients”Fang Zheng, Guozhong Gong, Yanwen Zhou et al.|International Journal of Infectious Diseases|2020Cited by 2